EUVIMEDEUVIMED entdecken
Open Access

Total cortical interstitial inflammation predicts chronic kidney disease progression in patients with lupus nephritis

Minh Dien Duong iD, Shudan Wang, Daniel Schwartz, Wenzhu B Mowrey, Anna Broder, Beatrice Goilav

Nephrology Dialysis Transplantation · 31.05.2023 · 38 (6) · 1469-1476

DOI: 10.1093/ndt/gfac286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 11.10.2022. Verfasst von Minh Dien Duong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nephrology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY, USA. Hauptthemen laut MEDLINE: Lupus Nephritis, Renal Insufficiency, Chronic, Kidney Failure, Chronic, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NIAMS NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

End-stage kidney disease (ESKD) from lupus nephritis (LN) is a major cause of morbidity and mortality in patients with systemic lupus erythematosus (SLE). Kidney biopsy is the gold standard for diagnosis and prognostication of LN. While interstitial fibrosis and tubular atrophy (IFTA) predict progression to ESKD, the National Institutes of Health (NIH) classification of interstitial inflammation in unscarred cortical parenchyma is not predictive of chronic kidney disease (CKD) progression. The objective of this study was to determine whether total cortical interstitial inflammation that accounts for inflammation in the entire cortical parenchyma could predict CKD progression in patients with LN. Early identification of at-risk patients may improve outcomes.

Methods

This retrospective cohort study included 125 SLE patients with LN class III, IV, V or mixed (III/V, IV/V) on the index biopsy (2005–2018). Kidney biopsies were reviewed and assigned based on the 2018 NIH Activity Index (AI) and tubulointerstitial lesion categories. Total interstitial inflammation in the entire cortical parenchyma was graded as 0, 1, 2 or 3, corresponding to <10%, 10–25%, 26–50% and >50%, respectively, of the total cortical parenchyma containing an inflammatory infiltrate (similar to the definition used in the Banff total inflammation score). CKD progression was defined as an estimated glomerular filtration rate decrease of ≥30% within 5 years after the index biopsy. Kaplan–Meier survival curves and Cox proportional hazards models were performed to compare the two scoring systems, the total cortical intestinal inflammation score and the NIH interstitial inflammation score as predictors of CKD progression.

Results

Of 125 patients, 46 experienced CKD progression; 21 of 46 subsequently developed ESKD, 28 (22.4%) had moderate–severe total cortical interstitial inflammation and 8 (6.4%) had moderate–severe NIH interstitial inflammation. There were no differences in baseline characteristics between progressors and nonprogressors. Total cortical interstitial inflammation was associated with CKD progression in time-dependent analyses [hazard ratio 2.45 (95% confidence interval 1.2–4.97)] adjusted for age at biopsy, race, sex, LN class and hypertensive vascular change on kidney biopsy. The NIH interstitial inflammation was not associated with CKD progression.

Conclusions

In contrast to the current NIH interstitial inflammation classification, accounting for interstitial inflammation in the entire cortical parenchyma allows identification of patients at risk for CKD progression in LN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus NephritisRenal Insufficiency, ChronicKidney Failure, ChronicLupus Erythematosus, SystemicHumansRetrospective StudiesInflammationBiopsyKidneyDisease Progression

Stichwörter der Autor:innen

CKD progressionSLEchronic kidney diseaseinterstitial inflammationlupus nephritis

Autor:innen und Institutionen

  • Department of Pediatrics, Nephrology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Department of Medicine, Rheumatology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Department of Surgical Pathology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Department of Epidemiology and Biostatistics, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Department of Medicine, Rheumatology, Hackensack University Medical Center, Hackensack, NJ, USA.

ORCID-Profile: Minh Dien Duong

Förderung

  • NCATS NIH HHS
  • NIAMS NIH HHS
  • NIH
  • National Center for Advancing Translational Sciences
  • NIAMS

Zitieren

APA

Duong, M. D., Wang, S., Schwartz, D., Mowrey, W. B., Broder, A., & Goilav, B. (2023). Total cortical interstitial inflammation predicts chronic kidney disease progression in patients with lupus nephritis. Nephrology Dialysis Transplantation, 38(6), 1469-1476. https://doi.org/10.1093/ndt/gfac286

Vancouver

Duong MD, Wang S, Schwartz D, Mowrey WB, Broder A, Goilav B. Total cortical interstitial inflammation predicts chronic kidney disease progression in patients with lupus nephritis. Nephrology Dialysis Transplantation. 2023;38(6):1469-1476. doi:10.1093/ndt/gfac286

BibTeX
@article{Duong2023,
  author = {Duong, Minh Dien and Wang, Shudan and Schwartz, Daniel and Mowrey, Wenzhu B and Broder, Anna and Goilav, Beatrice},
  title = {Total cortical interstitial inflammation predicts chronic kidney disease progression in patients with lupus nephritis},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  volume = {38},
  number = {6},
  pages = {1469--1476},
  doi = {10.1093/ndt/gfac286}
}
Kostenlos starten →